Alpha-1 antitrypsin gene polymorphism in Chronic Obstructive Pulmonary Disease (COPD)
AUTOR(ES)
Denden, Sabri, Khelil, Amel Haj, Knani, Jalel, Lakhdar, Ramzi, Perrin, Pascale, Lefranc, Gérard, Chibani, Jemni Ben
FONTE
Genetics and Molecular Biology
DATA DE PUBLICAÇÃO
18/12/2009
RESUMO
Alpha-1-antitrypsin (AAT) plays an important role in the pathogenesis of emphysema, the pathological lesion underlying the majority of the manifestations of Chronic Obstructive Pulmonary Disease (COPD). In this study we tested the hypothesis that common AAT polymorphisms influence the risk of developing COPDs. We investigated PiM1 (Ala213Val), PiM2 (Arg101His), PiM3 (Glu376Asp), PiS (Glu264Val) and PiZ (Glu342Lys) SERPINA1 alleles in 100 COPD patients and 200 healthy controls. No significant differences were observed in allele frequencies between COPD patients and controls, neither did haplotype analysis show significant differences between the two groups. A cross-sectional study revealed no significant relationship between common SERPINA1 polymorphisms (PiM1, PiM2, PiM3) and the emphysematous type of COPD. In addition, FEV1 annual decline, determined during a two-year follow up period, revealed no difference among carriers of the tested polymorphisms.
Documentos Relacionados
- Occupational and chronic obstructive pulmonary disease (COPD)
- Body composition and exercise performance in patients with chronic obstructive pulmonary disease (COPD)
- Mutation in the 3' region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease.
- Equine protease inhibitor system as a marker for the diagnosis of chronic obstructive pulmonary disease (COPD)
- Validation of the Airways Questionnaire 20 - AQ20 in patients with chronic obstructive pulmonary disease (COPD) in Brazil